tobacco leaf extract (NFL-101) / NFL Biosci 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tobacco leaf extract (NFL-101) / NFL Biosci
2022-002492-11: Phase II Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes Étude de phase II pour évaluer l'efficacité et la sécurité de NFL-101 sur la réduction des propriétés de renforcement des cigarettes

Not yet recruiting
2
34
Europe
NFL-101, Injection
NFL BIOSCIENCES SA, NFL BIOSCIENCES SA
Tobacco addiction, Tobacco addiction, Not possible to specify
 
 
PRECESTO, NCT06091826: Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes

Completed
2
34
Europe
NFL-101, Tobacco leaf extract, Placebo, Water for injection
NFL Biosciences SAS
Smoking Cessation, Nicotine Dependence
09/23
09/23
CESTO2, NCT04571216: Study Assessing Efficacy and Safety of NFL-101 as a Tobacco Cessation Therapy

Recruiting
2
318
Europe
NFL-101 dose 1, Tobacco leaf extract, NFL-101 dose 2, Placebo, WFI
NFL Biosciences SAS
Smoking Cessation, Nicotine Dependence
07/24
12/24

Download Options